SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-030243
Filing Date
2023-11-03
Accepted
2023-11-03 17:25:19
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A pbla20231103_defa14a.htm DEFA14A 46065
2 EXHIBIT 4.1 ex_591056.htm EX-4.1 129720
3 EXHIBIT 10.1 ex_591057.htm EX-10.1 55122
4 EXHIBIT 99.1 ex_591058.htm EX-99.1 19768
5 ex_591052img001.jpg GRAPHIC 5243
  Complete submission text file 0001437749-23-030243.txt   259260
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39468 | Film No.: 231377427
SIC: 2834 Pharmaceutical Preparations